Management of the Rh-negative mother.
D000649:Amniocentesis; D000653:Amniotic Fluid / Q000032:analysis; D001323:Autoantibodies / Q000032:analysis; D001663:Bilirubin / Q000032:analysis; D001805:Blood Transfusion, Intrauterine; D036861:Delivery, Obstetric; D004899:Erythroblastosis, Fetal / Q000175:diagnosis / Q000517:prevention & control*; D005260:Female; D005313:Fetal Death / Q000517:prevention & control; D005315:Fetal Diseases / Q000175:diagnosis; D006579:Heterozygote; D006720:Homozygote; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D008431:Maternal-Fetal Exchange; D010920:Placenta; D011247:Pregnancy; D012204:Rh-Hr Blood-Group System; D005719:gamma-Globulins / Q000627:therapeutic use
D001323:Autoantibodies; D012204:Rh-Hr Blood-Group System; D005719:gamma-Globulins; D001663:Bilirubin